The CDMO Expert

in Cell Therapy

Products

Cell-based therapies are not conventional Biologics,

they are living drugs…

…requiring cutting-edge expertise in Cell Culture.

0 +

Clinical Doses

manufactured in our state-of-the-art GMP facilities

0

Cell types

T cells, NK cells, T regs, MSCs, iPS cells, Macrophages, immortalized cell lines,…

0 +

Development Programs

Process Development, Optimization, Scale up.

Analytical & Potency test development.

0 +

ATMP Developers

TRUST US

from academic, to Biotech and Pharma companies

How SCIENCE plays out at Cell-Easy?

By combining solid technological and scientific knowledge in CELL CULTURE with conventional regulatory-controlled CDMO services, Cell-Easy’s multi-disciplinary team support you in transforming your laboratory proof-of-concept into a successful first-in-human clinical trial.

- 300+ cumulated years of cell culture experience
- Teams = PhDs, Engineers, Technicians in Cell Biology
- 70+ Technologies for Process & Analytics Development

- REGULATORY support adapted to cell products
- CMC driven by cell variability
- From concept to First-in-Human and beyond

- A dedicated Project Manager
- Co-define a robust roadmap
- Share Risks & Gaps during weekly meeting
- Avoid Change of Scope

- Accelerate Process Development/Scale-up with our Platforms
- Access expertise on 50+ different technologies
- Pre-established contract with providers

- Beyond agreements (NDA, MSA, QTA) our internal confidential policy protect your industrial secret
- As a fee for service CDMO, no IP is shared
- All documentation/production is Yours

- Respect TIMELINES
- Meet BUDGET
- Bring continous CMC and REGULATORY support
- Your SUCCESS is our goal

Cell-Easy is pleased to welcome Mrs. Gisele Deblandre, formerly CSO at MaSTherCell, as Chief Scientific Officer.

Toulouse, France, September 21st of 2023 Cell-Easy, a specialized contract development and manufacturing organization (CDMO) in cell therapy, proudly announces the appointment of Mrs. Gisele Deblandre as the Chief Scientific Officer.   Over the years, Cell-Easy has recognized the challenges faced by biotechs in bridging the gap between early-stage projects

Read More »

IUCT-Oncopole and Cell-Easy sign a MOU to accelerate cancer patient access to advanced cell-based therapy

TOULOUSE, FRANCE, June 22, 2023  IUCT-Oncopole and Cell-Easy SAS (Cell-Easy) announced today the signing of a Memorandum of Understanding to enhance their strategic collaborative relationship and open access to advanced cell-based therapies. This partnership aims to drive innovation in public health and improve access to promising new cancer therapies for patients.   By

Read More »

Cell-Easy Appoints CDMO Expert Dr. Ribault to Its Board

  TOULOUSE, France _ April 10, 2023 Cell-Easy is a leading contract development and manufacturing organization (CDMO) with a strong foothold in Good Manufacturing Practice (GMP) manufacturing services for immune cells (T, NK cells) and adult stem cells (MSCs, iPSCs). Since 2020, the company keeps expanding into genetically modified cells

Read More »

They Trust Us

Contact

Tel : +33 534 276 550
Address : Cell-Easy SAS, 4 bis avenue Hubert Curien, 31100 Toulouse, France
Mail : info@cell-easy.com